Finally, with regard to the impact of low BMI on external validity, this may also be seen as a strength, more certainly attributing the reduced incretin effect to diabetes, as obesity itself has also been shown to deteriorate the incretin effect.23 This evidence concerns the gene GCG and obesity disorder.